CONGENITAL FIBROSARCOMA

CONGENITAL FIBROSARCOMA was reported 3 times

CONGENITAL FIBROSARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1 0.0006
1 Actinomycin [EPC] 1 0.0005
2 Topoisomerase Inhibitor [EPC] 1 0.0000
3 Alkylating Drug [EPC] 1 0.0000
4 Kinase Inhibitor [EPC] 2 0.0000
5 Corticosteroid [EPC] 1 0.0000